Mediar Therapeutics, Inc., 2025-12-23
An SEC Form D private-offering notice from Boston, MA, a $75,699,630 filer-stated offering target in Biotech. Filed 2025-12-23. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotech developing first-in-class antibody therapies to halt fibrosis by targeting the myofibroblast.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Cross Domain Systems, Inc., 2025-12-23, $5.3M, Winchester, MA
- OrthoPreserve, Inc., 2025-12-23, $2M, Henrico, VA
- QuantumSafe Data Systems Inc., 2025-12-23, $12.6M, Norwell, MA
- Stratum Biosciences Inc., 2025-12-23, $550K, Madison, MS
- Square Robot, Inc., 2025-12-23, $15M, Westborough,, MA
- Nature's Toolbox, Inc., 2025-12-23, $15M, Rio Rancho, NM
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.